Introduction:
Precision medicine, an innovative approach to healthcare, aims to tailor medical treatments to individual patients based on their genetic, environmental, and lifestyle factors. Next-generation sequencing (NGS) technologies have played a pivotal role in advancing precision medicine by enabling rapid and cost-effective sequencing of entire genomes, leading to a deeper understanding of diseases and personalized treatment strategies. While NGS has been tested across multiple healthcare settings, its use is most advanced in oncology with physicians sequencing their patients’ tumors to match them to therapies designed to target the genetic alterations driving the tumor’s growth.
Challenges Faced By Client:
Although NGS technology has the advantage of a high-throughput workflow and can discover hereto unknown mutations but client faced several challenges such as technology, data management, data analysis, interpretation, reporting, and genetic consulting. Many publications and international consensus have reported the application of NGS in single-gene inheritance diseases and prenatal diagnostics, however, there has been no consensus on the application of NGS technology in clinical oncological practice, especially when used in cancer precision diagnosis and treatment to date.
Some of the major criteria put forth by the client are as follows:
- Data Management and Analysis: NGS generates vast amounts of genomic data, which requires robust data management and analysis pipelines. The analysis of NGS data is complex, and there is a need for advanced bioinformatics tools and computational infrastructure to handle and interpret the data accurately and efficiently
- Variant Interpretation and Clinical Relevance: Interpreting the vast amount of genetic variants identified through NGS is a significant challenge
- Integration with Clinical Workflows: Integrating NGS into routine clinical workflows and electronic health records (EHRs) poses challenges. There is a need for seamless integration of NGS data with clinical decision support systems and EHRs, enabling efficient and effective use of genetic information in patient care.
The client approached Data Bridge Market Research to address these aforementioned complex challenges and to understand what are the growth drivers present in the market for precision growth. Data Bridge Market Research, a trusted market research consulting firm renowned for its expertise in procurement consulting analyzed the feasibility of the project. Furthermore, the client wanted to know about the methods of next-generation sequencing and what are the quality requirements of NGS in cancer diagnosis. DBMR conducted a comprehensive analysis to get deeper insights.
